This map shows the geographic impact of Satoshi Iwata's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Iwata with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Iwata more than expected).
This network shows the impact of papers produced by Satoshi Iwata. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Iwata. The network helps show where Satoshi Iwata may publish in the future.
Co-authorship network of co-authors of Satoshi Iwata
This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Iwata.
A scholar is included among the top collaborators of Satoshi Iwata based on the total number of
citations received by their joint publications. Widths of edges
represent the number of papers authors have co-authored together.
Node borders
signify the number of papers an author published with Satoshi Iwata. Satoshi Iwata is excluded from
the visualization to improve readability, since they are connected to all nodes in the network.
Sunakawa, Keisuke, Kazunobu Ouchi, Satoshi Iwata, et al.. (2013). Clinical Efficacy of Tebipenem Pivoxil Treatment in Children with Pneumonia Classified According to Guideline-based Severity. 117(1). 75–81.1 indexed citations
Sunakawa, Keisuke, N Iwai, Satoshi Iwata, et al.. (2010). Population pharmacokinetics and pharmacodynamics of tosufloxacin granules in pediatric infectious diseases. 58. 69–77.4 indexed citations
7.
Sunakawa, Keisuke, Noboru Yamanaka, Satoshi Iwata, et al.. (2009). An open clinical study of tebipenem pivoxil in children with acute otitis media and acute upper respiratory tract infection (phase II). 57. 115–124.1 indexed citations
8.
Iwata, Satoshi, Kazunobu Ouchi, N Iwai, et al.. (2009). An open clinical study of tebipenem pivoxil in children with bacterial pneumonia. 57. 137–150.3 indexed citations
9.
Yamanaka, Noboru, Satoshi Iwata, Kyoichi Totsuka, et al.. (2009). A open clinical trial study of tebipenem pivoxil fine granule for treatment of pediatric patients with otorlaryngological infections. 57. 125–136.1 indexed citations
10.
Narita, Mitsuo, Norio Okazaki, Hitomi Ohya, et al.. (2008). S 3-6. Proposed antibiotic break points on Mycoplasma pneumoniae clinical isolates concerning macrolide and lincosamide antibiotics. 35. 59–60.2 indexed citations
11.
Iwata, Satoshi, Hiromi Kumon, Yoshihito Niki, et al.. (2007). Survey on once-daily therapy with ceftriaxone for pediatric bacterial infections. 55(6). 463–472.1 indexed citations
Chiba, Naoko, Keiko Hasegawa, Reiko Kobayashi, et al.. (2003). Epidemiology of Streptococcus pneumoniae isolates from patients with meningitis between 1993 and 2002. 51(9). 551–560.2 indexed citations
14.
Kobayashi, Intetsu, Hiroe Muraoka, Takeshi Saika, et al.. (1998). A mouse model of Escherichia coli .O157: H7 infection for evaluation of antibacterial drugs - In vivo release of verotoxins and toxic effect on mice. 46(3). 112–118.3 indexed citations
15.
Otsuka, Masaaki, Toshiharu Nakai, S Hasegawa, et al.. (1994). [Efficacy of combination therapy against MRSA in Ibaraki Prefecture].. PubMed. 47(6). 781–9.4 indexed citations
16.
Sato, Yoshitake, et al.. (1991). [Pharmacokinetic and clinical studies on flomoxef in neonates and premature infants].. PubMed. 44(11). 1240–9.2 indexed citations
17.
Sato, Yoshihisa, et al.. (1989). [Pharmacokinetic, bacteriological and clinical studies on cefpodoxime proxetil in the field of pediatrics].. PubMed. 42(7). 1547–60.1 indexed citations
18.
Sato, Yoshitake, et al.. (1985). [Fundamental and clinical studies of ceftizoxime suppositories in the pediatric field].. PubMed. 38(10). 2877–88.1 indexed citations
19.
Iwata, Satoshi, Hiroyuki Hattori, Ryo Wakabayashi, et al.. (1982). From the Teacher to the Top.. PubMed. 35(2). 429–37.2 indexed citations
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive
bibliographic database. While OpenAlex provides broad and valuable coverage of the global
research landscape, it—like all bibliographic datasets—has inherent limitations. These include
incomplete records, variations in author disambiguation, differences in journal indexing, and
delays in data updates. As a result, some metrics and network relationships displayed in
Rankless may not fully capture the entirety of a scholar's output or impact.